Oncolytics Bio (ONC.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Operating Expenses | 13,840 | 5,706 | 6,999 | 8,437 | 9,899 |
| Operating Income | -13,840 | -5,706 | -6,999 | -8,437 | -9,899 |
| Other Income | -812 | -374 | 312 | 443 | 368 |
| Pre-tax Income | -14,652 | -6,080 | -6,687 | -7,994 | -9,531 |
| Income Tax | -252 | 85 | N/A | 23 | 12 |
| Net Income Continuous | -14,400 | -6,165 | -6,687 | -8,017 | -9,543 |
| Net Income | $-14,400 | $-6,165 | $-6,687 | $-8,017 | $-9,543 |
| EPS Basic Total Ops | N/A | -0.07 | -0.08 | -0.10 | -0.12 |
| EPS Basic Continuous Ops | N/A | -0.07 | -0.08 | -0.10 | -0.12 |
| EPS Diluted Total Ops | N/A | -0.07 | -0.08 | -0.10 | -0.12 |
| EPS Diluted Continuous Ops | N/A | -0.07 | -0.08 | -0.10 | -0.12 |
| EBITDA(a) | $-13,747 | $-5,612 | $-6,902 | $-8,339 | $-9,794 |